Cargando…

Evaluation of novel obesity- and lipid-related indices as predictors of abnormal glucose tolerance in Chinese women with polycystic ovary syndrome

PURPOSE: We aimed to evaluate the performance of Chinese visceral adiposity index (CVAI), visceral adiposity index (VAI), lipid accumulation product (LAP), triglyceride glucose (TyG) as indices in screening abnormal glucose tolerance (AGT) in Chinese women with polycystic ovary syndrome (PCOS), usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Qianqian, Yan, Xiaonan, Cao, Yijuan, Zheng, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644461/ https://www.ncbi.nlm.nih.gov/pubmed/36348340 http://dx.doi.org/10.1186/s12902-022-01179-0

Ejemplares similares

Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
por: Yin, Qianqian, et al.
Publicado: (2021)

Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome
por: Kałużna, Małgorzata, et al.
Publicado: (2022)

Predictive capability of fasting-state glucose and insulin measurements for abnormal glucose tolerance in women with polycystic ovary syndrome
por: Chun, Sungwook
Publicado: (2021)

Role of Haptoglobin in Polycystic Ovary Syndrome (PCOS), Obesity and Disorders of Glucose Tolerance in Premenopausal Women
por: Álvarez-Blasco, Francisco, et al.
Publicado: (2009)

Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity
por: Gupta, Jyotsna, et al.
Publicado: (2022)

Homocysteine is an indicator of arterial stiffness in Chinese women with polycystic ovary syndrome
por: Wu, Xia, et al.
Publicado: (2021)

Triglyceride and glucose index for identifying abnormal insulin sensitivity in women with polycystic ovary syndrome
por: Kwon, Seeun, et al.
Publicado: (2023)

Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Analysis of Methylome, Transcriptome, and Lipid Metabolites to Understand the Molecular Abnormalities in Polycystic Ovary Syndrome
por: Zhang, Fei, et al.
Publicado: (2023)

The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study
por: Tehrani, Fahimeh Ramezani, et al.
Publicado: (2011)

The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
por: Wang, Haiyan, et al.
Publicado: (2023)

The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level
por: Bu, Zhiqin, et al.
Publicado: (2012)

Assessment of glucose and lipid metabolism in patients with polycystic ovary syndrome with and without Hashimoto’s thyroiditis
por: Jia, Cenlin, et al.
Publicado: (2023)

Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome
por: Du, Juan, et al.
Publicado: (2021)

Association between insulin resistance and abnormal menstrual cycle in Chinese patients with polycystic ovary syndrome
por: Niu, Jiali, et al.
Publicado: (2023)

Systematic Evaluation of Genetic Variants for Polycystic Ovary Syndrome in a Chinese Population
por: Xu, Yuping, et al.
Publicado: (2015)

Metabolic abnormalities in adolescents with polycystic ovary syndrome in south china
por: Huang, Jia, et al.
Publicado: (2010)

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
por: Shan, Hongying, et al.
Publicado: (2022)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

The Impact of Abnormal Glucose Tolerance and Obesity on Fetal Growth
por: Graves, Erin, et al.
Publicado: (2015)

The effect of body mass index on neonatal outcomes in Chinese women with polycystic ovary syndrome
por: Guo, Haiyan, et al.
Publicado: (2022)

Dietary Patterns and Glucose Tolerance Abnormalities in Chinese Adults
por: He, Yuna, et al.
Publicado: (2009)

Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance
por: Song, Do Kyeong, et al.
Publicado: (2017)

Does polycystic ovary syndrome affect morphokinetics or abnormalities in early embryonic development?()
por: Tam Le, Minh, et al.
Publicado: (2019)

Neck Circumference as a Predictor of Obesity and Metabolic Syndrome in Bangladeshi Women with Polycystic Ovary Syndrome
por: Kamrul-Hasan, A. B. M., et al.
Publicado: (2021)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

Insulin level, lipid profile, and HOMA index in lean and obese patients with polycystic ovary syndrome
por: Hussein, Shamim Riadh Mohammed, et al.
Publicado: (2023)

Association Between Fasting Blood Glucose and Carotid Intima-Media Thickness of Polycystic Ovary Syndrome Patients With Normal Glucose Tolerance
por: Son, Kuk Hui, et al.
Publicado: (2013)

Regulation of Insulin Resistance, Lipid Profile and Glucose Metabolism Associated with Polycystic Ovary Syndrome by Tinospora cordifolia
por: Rani, Ritu, et al.
Publicado: (2023)

The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
por: Chang, Chia Lin, et al.
Publicado: (2019)

Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium
por: Xue, Zhu, et al.
Publicado: (2021)

Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome
por: Wang, Siyu, et al.
Publicado: (2022)

Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
por: Karakas, Sidika E., et al.
Publicado: (2010)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

Predictors of Metabolic Syndrome among Polycystic Ovary Syndrome Sisters
por: Kulshreshtha, Bindu, et al.
Publicado: (2019)

Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats
por: Zhai, Hua-Ling, et al.
Publicado: (2012)

miR-141-3p is Poorly Expressed in Polycystic Ovary Syndrome and Correlates with Glucose and Lipid Metabolism
por: Fan, Lingye, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iis4fab6k65cnctm2sa3hn6g4t